Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Feb;4(1):35-40.
doi: 10.4021/cr252w. Epub 2013 Mar 8.

Potential for Infra-Nodal Heart Block and Cardiogenic Shock With Propofol Administration

Affiliations
Case Reports

Potential for Infra-Nodal Heart Block and Cardiogenic Shock With Propofol Administration

Nicholas Olson et al. Cardiol Res. 2013 Feb.

Abstract

We report a case of infra-nodal complete heart block and cardiogenic shock in a previously healthy 64-year-old man after administration of 180 mg of intravenous Propofol. Although bradycardia, hypotension, and heart block are commonly seen with propofol administration, such findings are transient and respond quickly to administration of vagolytic or sympathomimetic agents suggesting an AV nodal mechanism of heart block. Sustained left ventricular systolic dysfunction and cardiogenic shock by an alternative, non-autonomic mechanism has also been described in the setting of Propofol administration. Our case is the first to note sustained complete infra-nodal heart block in this setting. Early recognition of such a complication, restoration of atrio-ventricular (A-V) synchrony with dual chamber pacing, and aggressive circulatory support is essential in bridging such patients to recovery.

Keywords: Anesthesia; Cardiogenic shock; Cardiomyopathy; Heart block; Heart failure; Hypotension; Impella; Left ventricular assist device; Propofol; Propofol infusion syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pre-operative ECG demonstrating RBBB, PR interval of 190, and QRS duration of 150 msec.
Figure 2
Figure 2
Post implantation of a single lead VVI transvenous pacemaker demonstrating sinus tachycardia at 150 bpm, complete heart block, and ventricular demand pacing at 100 bpm.
Figure 3
Figure 3
Day 5 ECG demonstrating a PR interval of 230 msec and a QRS duration of 150 msec with LBBB morphology.
Figure 4
Figure 4
Day 5 ECG demonstrating PR interval of 190 msec and QRS duration of 150 msec with RBBB morphology and Mobitz type 2 AV block.
Figure 5
Figure 5
Day 6 ECG demonstrating baseline RBBB, PR interval of 188 msec and QRS duration of 150 msec.

Similar articles

Cited by

References

    1. Morgan DJ, Campbell GA, Crankshaw DP. Pharmacokinetics of propofol when given by intravenous infusion. Br J Clin Pharmacol. 1990;30(1):144–148. doi: 10.1111/j.1365-2125.1990.tb03755.x. - DOI - PMC - PubMed
    1. Hug CC Jr, McLeskey CH, Nahrwold ML, Roizen MF, Stanley TH, Thisted RA, Walawander CA. et al. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg. 1993;77(4 Suppl):S21–29. - PubMed
    1. Ebert TJ. Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans. Anesthesiology. 2005;103(1):20–24. doi: 10.1097/00000542-200507000-00007. - DOI - PubMed
    1. Robinson BJ, Ebert TJ, O'Brien TJ, Colinco MD, Muzi M. Mechanisms whereby propofol mediates peripheral vasodilation in humans. Sympathoinhibition or direct vascular relaxation? Anesthesiology. 1997;86(1):64–72. doi: 10.1097/00000542-199701000-00010. - DOI - PubMed
    1. Sprung J, Ogletree-Hughes ML, McConnell BK, Zakhary DR, Smolsky SM, Moravec CS. The effects of propofol on the contractility of failing and nonfailing human heart muscles. Anesth Analg. 2001;93(3):550–559. doi: 10.1097/00000539-200109000-00006. - DOI - PubMed

Publication types

LinkOut - more resources